Investor Relations

Investor
Relations

Investor Communications

NorthStar Healthcare’s Q3 2022 Results and Estimated NAV Update Conference Call

Monday, November 21, 2022

Click Here to Listen to the Replay

 

Investor Presentation - Internalization of Management

Investor Presentation NHI Internalization, October 2022

 

Frequently Asked Questions

Updated October 21, 2022

Click here to download the Frequently Asked Questions PDF

 

Supplemental Financial Reports 

Third Quarter 2022 Financial Supplement – 11.10.2022

Second Quarter 2022 Financial Supplement – 8.12.22

First Quarter 2022 Financial Supplement – 5.13.22

Fourth Quarter 2021 Financial Supplement – 3.18.22

Third Quarter 2021 Financial Supplement – 11.12.21

Second Quarter 2021 Financial Supplement – 8.13.21

First Quarter 2021 Financial Supplement - 5.14.21

Year Ended 2020 Financial Supplement - 3.23.21

Financial Supplemental Update - 1.27.21

Third Quarter 2020 Financial Supplement - 9.30.20

Second Quarter 2020 Financial Supplement - 8.13.20

COVID-19 Update Supplement – 5.27.2020

First Quarter 2020 Financial Supplement – 5.08.2020

Year Ended 2019 Financial Supplement - 3.23.20

Third Quarter 2019 Financial Supplement - 11.14.19

Second Quarter 2019 Financial Supplement - 8.19.19

First Quarter 2019 Financial Supplement - 6.14.19

 

Shareholder Letters

Suspension of the Distribution Reinvestment Plan - 4.12.2022

June 30, 2021 Estimated Per Share Value – 11.18.2021

Response to Comrit Tender Offer - 4.27.2021

June 30, 2020 Estimated Per Share Value - 12.21.2020

Response to Comrit Tender Offer - 12.4.2020

Share Repurchase Program Suspension - 4.14.2020

June 30, 2019 Estimated Per Share Value - 12.11.2019

Response to Comrit Tender Offer - 12.11.2019

Monthly Distribution Suspension - 2.7.2019

Amended Share Repurchase Program - 10.15.2018

Response to MacKenzie Tender Offer - 8.13.2018